These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21094539)

  • 1. The influence of inflammation outweighing the metabolic syndrome on cardiovascular risk and mortality.
    Lin GM; Chu KM; Han CL
    Int J Cardiol; 2011 Feb; 146(3):431. PubMed ID: 21094539
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic syndrome, diabetes and cardiovascular events: current controversies and recommendations.
    Zarich SW
    Minerva Cardioangiol; 2006 Apr; 54(2):195-214. PubMed ID: 16778752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic syndrome and cardiometabolic risk: scope of the problem and current standard of care.
    Lender D; Sysko SK
    Pharmacotherapy; 2006 May; 26(5 Pt 2):3S-12S. PubMed ID: 16637782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemic obesity and the metabolic syndrome.
    Haffner S; Taegtmeyer H
    Circulation; 2003 Sep; 108(13):1541-5. PubMed ID: 14517149
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic syndrome and cardiovascular disease.
    Qiao Q; Gao W; Zhang L; Nyamdorj R; Tuomilehto J
    Ann Clin Biochem; 2007 May; 44(Pt 3):232-63. PubMed ID: 17456293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic syndrome and its cardiovascular manifestations.
    Sánchez-Torres RJ; Delgado-Osorio H
    Bol Asoc Med P R; 2005; 97(4):271-80. PubMed ID: 16599068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic syndrome is associated with subclinical atherosclerosis independent of insulin resistance: the Guangzhou Biobank Cohort Study-CVD.
    Xu L; Jiang CQ; Lam TH; Lin JM; Yue XJ; Cheng KK; Liu B; Jin YL; Zhang WS; Thomas GN;
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):181-8. PubMed ID: 20039893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome.
    Reaven P
    J Insur Med; 2004; 36(2):132-42. PubMed ID: 15301226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic syndrome in women.
    Schneider JG; Tompkins C; Blumenthal RS; Mora S
    Cardiol Rev; 2006; 14(6):286-91. PubMed ID: 17053375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome: what's in a name?
    Wubben DP; Adams AK
    WMJ; 2006 Jul; 105(5):17-20. PubMed ID: 16933408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State of the heart in the metabolic syndrome.
    de Simone G
    Nutr Metab Cardiovasc Dis; 2005 Aug; 15(4):239-41. PubMed ID: 16054546
    [No Abstract]   [Full Text] [Related]  

  • 12. The 2009 stock conference report: inflammation, obesity and metabolic disease.
    Hevener AL; Febbraio MA;
    Obes Rev; 2010 Sep; 11(9):635-44. PubMed ID: 20002885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study.
    Hunt KJ; Resendez RG; Williams K; Haffner SM; Stern MP;
    Circulation; 2004 Sep; 110(10):1251-7. PubMed ID: 15326061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk in the spectrum of type 2 diabetes mellitus.
    Ahmed I; Goldstein BJ
    Mt Sinai J Med; 2006 Sep; 73(5):759-68. PubMed ID: 17008936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of insulin resistance in the obese with metabolic syndrome.
    Manu P; Tsang J; Napolitano BA; Lesser ML; Correll CU
    Eur J Intern Med; 2010 Oct; 21(5):409-13. PubMed ID: 20816595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic syndrome: more than the sum of its parts?
    Reilly MP; Rader DJ
    Circulation; 2003 Sep; 108(13):1546-51. PubMed ID: 14517150
    [No Abstract]   [Full Text] [Related]  

  • 17. Relation of the number of metabolic syndrome risk factors with all-cause and cardiovascular mortality.
    Ho JS; Cannaday JJ; Barlow CE; Mitchell TL; Cooper KH; FitzGerald SJ
    Am J Cardiol; 2008 Sep; 102(6):689-92. PubMed ID: 18773989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk and the urological patient.
    Kirby M; Kirby R
    BJU Int; 2009 Nov; 104(9):1185-6. PubMed ID: 19583722
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin resistance and inflammation in the early phase of type 2 diabetes: potential for therapeutic intervention.
    Schernthaner GH; Schernthaner G
    Scand J Clin Lab Invest Suppl; 2005; 240():30-40. PubMed ID: 16112958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cardiometabolic syndrome in the adolescent.
    Gardner M; Gardner DW; Sowers JR
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():964-8. PubMed ID: 18806711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.